Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Craig-Hallum Initiates Coverage of Veracyte With Buy Rating, $45 Price Target
The investment bank views the company as a promising target with a strong track record and prospects for expansion into new, under-penetrated markets.
The firm has multiple infectious disease tests in its pipeline and is currently in initial conversations with potential investors and partners.
Cepheid to Lay off 167 Employees
The employees are located in California's Alameda County, San Joaquin County, and Santa Clara County.
Leaders from diagnostics firms and academia discussed the challenges of assessing these tests and the need for a consensus on how to bring them to the clinic.
AccuStem Sciences Acquires Lung Cancer Screening Test From Italian University Researchers
AccuStem plans to commercialize the MicroRNA Signature Classifier test and launch it in the US in 2026.